MYGN
Myriad Genetics (MYGN)
NASDAQ
$3.08+$0.22 (+7.52%)
Price as of Aug 03, 2026 10:21 AM EDT
  • $270.1M
    Market Cap
  • -26.85%
    1-Year Change
  • Diagnostics & Research
    Industry
MYGN
vs History
vs S&P 500
General Statistics
Latest Close
$2.86
Change
-$2.51 (-46.74%)
Open
$3.10
High
$3.26
Low
$2.81
Previous Close
$5.37
Volume
15,162,792
30-Day Average Volume
1,702,550
1-Week Change
-49.02%
1-Month Change
-49.91%
1-Year Change
-26.85%
3-Year Change
-87.20%
5-Year Change
-90.96%
Fundamentals
Shares Outstanding
94.4M
Total Assets
$638.9M
Market Cap
$270.1M
Enterprise Value
$275.6M
Period:
QTR
TTM
FY
Revenue
$190.7M
Net Income
-$43.2M
Free Cash Flow
-$8.3M
EBIT
-$42.6M
EBITDA
-$30.1M
Net Working Capital
$158.3M
EPS
-$0.46
Enterprise Value/EBITDA
-9
Enterprise Value/Revenue
1
P/B
1
P/E
-6
PEG
0
Price/Free Cash Flow
-33
Price/Operating Cash Flow
-33
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
2 : 1
Last Split Date
03/26/2009

Earnings & Revenue